DefEYE, Inc. Announces Investment from ExSight Ventures

NEW YORK--(BUSINESS WIRE)--ExSight Ventures, a leading venture capital firm focused on transformational eye care innovations, today announced its investment in DefEYE, Inc., a rapidly growing ocular company developing decellularized placental-based tissue solutions to transform and personalize therapeutic approaches in eye care. DefEYE is pioneering the ocular biologics landscape with an innovative approach to both ocular surface disease and ocular surgical management. The company is focused on